PURPOSE: To determine the sensitivity and specificity of confocal scanning laser ophthalmoscope's Topographic Change Analysis (TCA; Heidelberg Retina Tomograph [HRT]; Heidelberg Engineering, Heidelberg, Germany) parameters for discriminating between progressing glaucomatous and stable healthy eyes. METHODS: The 0.90, 0.95, and 0.99 specificity cutoffs for various (n=70) TCA parameters were developed by using 1000 permuted topographic series derived from HRT images of 18 healthy eyes from Moorfields Eye Hospital, imaged at least four times. The cutoffs were then applied to topographic series from 36 eyes with known glaucomatous progression (by optic disc stereophotograph assessment and/or standard automated perimetry guided progression analysis, [GPA]) and 21 healthy eyes from the University of California, San Diego (UCSD) Diagnostic Innovations in Glaucoma Study (DIGS), all imaged at least four times, to determine TCA sensitivity and specificity. Cutoffs also were applied to 210 DIGS patients' eyes imaged at least four times with no evidence of progression (nonprogressed) by stereophotography or GPA. RESULTS: The TCA parameter providing the best sensitivity/specificity tradeoff using the 0.90, 0.95, and 0.99 cutoffs was the largest clustered superpixel area within the optic disc margin (CAREA(disc) mm(2)). Sensitivities/specificities for classifying progressing (by stereophotography and/or GPA) and healthy eyes were 0.778/0.809, 0.639/0.857, and 0.611/1.00, respectively. In nonprogressing eyes, specificities were 0.464, 0.570, and 0.647 (i.e., lower than in the healthy eyes). In addition, TCA parameter measurements of nonprogressing eyes were similar to those of progressing eyes. CONCLUSIONS: TCA parameters can discriminate between progressing and longitudinally observed healthy eyes. Low specificity in apparently nonprogressing patients' eyes suggests early progression detection using TCA.
PURPOSE: To determine the sensitivity and specificity of confocal scanning laser ophthalmoscope's Topographic Change Analysis (TCA; Heidelberg Retina Tomograph [HRT]; Heidelberg Engineering, Heidelberg, Germany) parameters for discriminating between progressing glaucomatous and stable healthy eyes. METHODS: The 0.90, 0.95, and 0.99 specificity cutoffs for various (n=70) TCA parameters were developed by using 1000 permuted topographic series derived from HRT images of 18 healthy eyes from Moorfields Eye Hospital, imaged at least four times. The cutoffs were then applied to topographic series from 36 eyes with known glaucomatous progression (by optic disc stereophotograph assessment and/or standard automated perimetry guided progression analysis, [GPA]) and 21 healthy eyes from the University of California, San Diego (UCSD) Diagnostic Innovations in Glaucoma Study (DIGS), all imaged at least four times, to determine TCA sensitivity and specificity. Cutoffs also were applied to 210 DIGS patients' eyes imaged at least four times with no evidence of progression (nonprogressed) by stereophotography or GPA. RESULTS: The TCA parameter providing the best sensitivity/specificity tradeoff using the 0.90, 0.95, and 0.99 cutoffs was the largest clustered superpixel area within the optic disc margin (CAREA(disc) mm(2)). Sensitivities/specificities for classifying progressing (by stereophotography and/or GPA) and healthy eyes were 0.778/0.809, 0.639/0.857, and 0.611/1.00, respectively. In nonprogressing eyes, specificities were 0.464, 0.570, and 0.647 (i.e., lower than in the healthy eyes). In addition, TCA parameter measurements of nonprogressing eyes were similar to those of progressing eyes. CONCLUSIONS:TCA parameters can discriminate between progressing and longitudinally observed healthy eyes. Low specificity in apparently nonprogressing patients' eyes suggests early progression detection using TCA.
Authors: Christopher Bowd; Linda M Zangwill; Eytan Z Blumenthal; Cristiana Vasile; Andreas G Boehm; Parag A Gokhale; Kourosh Mohammadi; Payam Amini; Timothy M Sankary; Robert N Weinreb Journal: J Opt Soc Am A Opt Image Sci Vis Date: 2002-01 Impact factor: 2.129
Authors: Marcelo T Nicolela; Terry A McCormick; Stephen M Drance; Suzanne N Ferrier; Raymond P LeBlanc; Balwantray C Chauhan Journal: Ophthalmology Date: 2003-11 Impact factor: 12.079
Authors: Lin He; Hongli Yang; Stuart K Gardiner; Galen Williams; Christy Hardin; Nicholas G Strouthidis; Brad Fortune; Claude F Burgoyne Journal: Invest Ophthalmol Vis Sci Date: 2014-01-29 Impact factor: 4.799
Authors: Christopher Bowd; Intae Lee; Michael H Goldbaum; Madhusudhanan Balasubramanian; Felipe A Medeiros; Linda M Zangwill; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2012-04-30 Impact factor: 4.799
Authors: Michele M Iester; Gadi Wollstein; Richard A Bilonick; Juan Xu; Hiroshi Ishikawa; Larry Kagemann; Joel S Schuman Journal: Br J Ophthalmol Date: 2014-10-21 Impact factor: 4.638
Authors: Madhusudhanan Balasubramanian; Christopher Bowd; Robert N Weinreb; Gianmarco Vizzeri; Luciana M Alencar; Pamela A Sample; Neil O'Leary; Linda M Zangwill Journal: Invest Ophthalmol Vis Sci Date: 2009-08-06 Impact factor: 4.799
Authors: Na'ama Hammel; Akram Belghith; Christopher Bowd; Felipe A Medeiros; Lucie Sharpsten; Nadia Mendoza; Andrew J Tatham; Naira Khachatryan; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill Journal: Ophthalmology Date: 2015-12-30 Impact factor: 12.079
Authors: Lindsey S Folio; Gadi Wollstein; Jacek Kotowski; Richard A Bilonick; Yun Ling; Hiroshi Ishikawa; Larry Kagemann; Joel S Schuman Journal: Br J Ophthalmol Date: 2012-11-30 Impact factor: 4.638